Clinical characteristics and outcome of children with biphenotypic acute leukemia

Haematologica

Volumn 94, Issue 12, 2009, Pages 1682-1690

  Al Seraihy, Amal S ^a   Owaidah, Tarek M ^a   Ayas, Mouhab ^a   El Solh, Hassan ^a   Al Mahr, Mohammed ^a   Al Ahmari, Ali ^a   Belgaumi, Asim F ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Biphenotypic acute leukemia; Diagnosis; Immunophenotyping; Stem cell transplant; Therapy

Indexed keywords

ANTILEUKEMIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW CELL; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 14Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS INFUSION; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; INFANT; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; MYCOSIS; PHENOTYPE; PRE B LYMPHOCYTE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SCORING SYSTEM; SPINAL CORD METASTASIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KAPLAN-MEIERS ESTIMATE; KARYOTYPING; LEUKEMIA, BIPHENOTYPIC, ACUTE; MALE; OUTCOME ASSESSMENT (HEALTH CARE); REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 73149110129     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.009282     Document Type: Review

References (21)

1. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. For the European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995;9: 1783-6.
2. Borowitz MJ, Bene MC, Harris NL, Porwit A, Matutes E. Acute leukemias of ambiguous lineage. In: Swerdlow SH, Campo E, Harris NL, et al, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyons: IARC Press;2008:150-5.
3. Urbano-Ispizua A, Matutes E, Villamor N, Ribera JM, Feliu E, Montserrat E, et al. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia. Br J Haematol 1990;75:202-7.
4. Buccheri V, Matutes E, Dyer MJS, Catovsky D. Lineage commitment in biphenotypic acute leukemia. Leukemia 1993;7:919-27.
5. Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, et al. Definition of acute biphenotypic leukemia. Haematologica 1997;82: 64-6.
6. Owaidah TM, Al Beihany A, Iqbal MA, Elkum N, Roberts GT. Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system. Leukemia 2006;20:620-6.
7. Killick S, Matutes E, Powles RL, Hamblin M, Swansbury J, Treleaven JG, et al. Outcome of biphenotypic acute leukemia. Hematologica 1999; 84:699-706.
8. Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, Jaeger U, Lechner K, Schneider B, et al. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol 2002;117:380-9.
9. Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, et al. Acute mixed lineage leukemia in children: The experience of St. Jude Children's Research Hospital. Blood 2009;113:5083-9.
10. Park JA, Ghim TT, Bae KW, Im HJ, Jang SS, Park CJ, et al. Stem cell transplant in the treatment of childhood biphenotypic acute leukemia. Pediatr Blood Cancer 2009;53:444-52.
11. Legrand O, Perrot JY, Simonin G, Baudard M, Cadiou M, Blanc C, et al. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol 1998;10:147-55.
12. Rubio MT, Dhedin N, Boucheix C, Bourhis JH, Reman O, Boiron JM, et al. Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome. Br J Haematol 2003;123:842-9.
13. Lee M-Y, Tan T-D, Feng A-C. Clinicopathologic analysis of acute myeloid leukemia in a single institution: biphenotypic acute myeloid leukemia may not be an aggressive subtype. J Chin Med Assoc 2007;70: 269-73.
14. Aribi A, Bueso-Ramos C, Estey E, Estrov Z, O'Brien S, Giles F, et al. Biphenotypic acute leukemia: a case series. Br J Haematol 2007;138:213-6.
15. Pui C-H, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St. Jude Children's Research Hospital. Blood 2004;104:2690-6.
16. Uckun FM, Gaynon P, Sather H, Arthur DC, Trigg ME, Tubergen DG, et al. Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 1997;89: 2488-93.
17. Shetty V, Chitale A, Matutes E, Buccheri V, Morilla R, Catovsky D. Immunological and ultrastructural studies in acute biphenotypic leukemia. J Clin Pathol 1993;46:903-7.
18. Sulak LE, Clare CN, Morale BA, Hansen KL, Montiel MM. Biphenotypic acute leukemia in adults. Am J Clin Pathol 1990;94:54-8.
19. Hayashi Y, Pui CH, Behm FG, Fuchs AH, Raimondi SC, Kitchingman GR, et al. 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia. Blood 1990;76:150-6.
20. Pui CH, Rubnitz JE, Hancock ML, Downing JR, Raimondi SC, Rivera GK, et al. Reappraisal of the clinical and biological significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol 1998;16: 3768-73.
21. Putti MC, Rondelli R, Cocito MG, Aricó M, Sainati L, Conter V, et al. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood 1998;92:795-801.